RE:New Published Evidence of Apabetalone’s Beneficial Effects o awesome, thanks for posting! ABOUT TIME!!!
BUT.....sigh.....more questions remain, at least for me! What journal is this published in? I think it matters, it might not, guess we'll set at market open, bc:
Unfortunately, from this NR: "The article, titled:
“Bromodomain and Extraterminal Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection (Pre-Clinical)”, was published on the pre-print server, bioRxiv, at the request of the reviewing scientific journal."
So, what journal?
Hopefully bioRxiv is not the extent of publishing cause... from wikipedia: https://en.wikipedia.org/wiki/BioRxiv
"As preprints,
papers hosted on bioRxiv are not peer-reviewed, but undergo basic screening and checked against plagiarism."
so, is our paper some fluff piece posted online, dressed up as something that hasn't been peer-reviewed and not published in a bone-fide respected journal?
And this:
https://www.biorxiv.org/about/FAQ
"bioRxiv is not a journal so it has no Impact Factor."
So we're not "published" yet? This is going to a real journal? or this is as good of a publication as we're gonna get"
if this is the only exposure, then my guess is this won't do much for us, sorry.....
why is nothing easy with this company?!?!?!?!?! anyways, i'll be hawking the opening bell as i'm sure we all will be....